New research finds that people with color vision deficiency may miss an early and crucial sign of bladder cancer, which could lead to delayed diagnosis and higher long-term mortality. A study of medical records tied colorblindness to a significantly increased 20-year death rate among bladder cancer patients, and experts are urging awareness, routine testing, and simple adjustments in clinical care. The focus is practical: recognize the gap, alert clinicians, and use objective testing rather than relying on color perception alone.
Color vision problems mostly affect men, with roughly 8% estimated to have some form of color vision deficiency compared with about 0.5% of women. The most common difficulty is distinguishing reds and greens, which quietly shapes how people notice changes in bodily cues. That everyday challenge becomes medically relevant when the earliest warning sign of bladder cancer often presents as visible blood in the urine.
Blood in the urine is the single most common initial symptom that propels patients into further testing and diagnosis. If someone cannot reliably perceive red tones, that symptom can be missed or dismissed, producing dangerous delays. The study in question looked at long-term outcomes and suggests those delays translate into measurable survival differences.
Researchers publishing in Nature Health analyzed health records and tracked outcomes over two decades, finding a 52% higher mortality rate among bladder cancer patients who also had color vision deficiency. That percentage represents a real and sizable gap in outcomes that deserves attention from clinicians and patients alike. Bladder cancer itself remains far more common in men, roughly four times the rate seen in women, which compounds the public-health significance of color vision gaps.
Ehsan Rahimy, M.D., an adjunct clinical associate professor of ophthalmology, voiced a clear hope: “hopeful this study raises some awareness, not only for patients with colorblindness, but for our colleagues who see these patients.” That kind of awareness starts with a note in the chart and a little extra counseling during routine visits. Making the visual limitation explicit changes how symptoms are interpreted and how quickly follow-up testing is ordered.
Ophthalmology experts warn the risk is tangible. The inability to recognize the color red in this scenario is a “real risk.” “The patient, family and medical doctor should be made aware of this potential gap in diagnosis,” another specialist said, adding, “It is important to raise awareness of potential issues in making the diagnosis of bladder or kidney cancer in colorblind individuals.”
Diagnosis delays can cascade into worse stages at presentation and fewer treatment options. “My guess is that many doctors may not be looking closely enough at the medical record to pick up on this eye problem, leading to delays in diagnosis as the patient may not be able to see the issue,” the expert observed. That simple miss in medical history can change the whole trajectory of care for a patient.
Clinicians and patients can take immediate, low-cost steps. Inform your primary care doctor if you struggle to distinguish colors, request a urine test at annual exams, and ask for objective laboratory screening rather than relying on visual checks alone. If a partner or spouse is available, having someone else confirm an unusual urine color is a practical short-term fix.
Optometrists emphasize straightforward counseling and testing. “This is the kind of small detail in a medical history that can change how we counsel patients on the symptoms they should never ignore,” one clinician said. “The takeaway is simple: Don’t rely on color alone to detect a problem. Bladder cancer can present as painless bleeding, and if you ever suspect blood in your urine, you should alert your doctor.”
Practical vigilance pays off: “If the color of urine looks “off” — for example, is tea-colored or unusually dark — the patient should be checked “promptly.” “This study is a strong reminder to tailor health guidance to real-world differences and variations, including color vision,” the clinician added. “Colorblindness doesn’t cause bladder cancer, but it may make the earliest warning sign easier to miss,” he said. “The fix is awareness and simple testing, not fear.”
